Ana García

Ana García

Auto-generated profile, based on publicly available information

Ana García

Instituto de Quimica Organica, CSIC, Juan de la Cierva 3, E-28006 Madrid, Spain

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2005 in Chemical Reviews
Verified
Journal Article
Closed access
AVAlma Viso
Alma Viso
RPRoberto Fernández de la Pradilla
Roberto Fernández de la Pradilla
AGAna García
Ana García
AFAida Flores
Aida Flores

9 February 2011 in Chemical Reviews
Verified
Journal Article
Closed access
AVAlma Viso
Alma Viso
RPRoberto Fernández de la Pradilla
Roberto Fernández de la Pradilla
MTMariola Tortosa
Mariola Tortosa
AGAna García
Ana García
AFAida Flores
Aida Flores

2 November 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
MMMarinela Méndez-Pertuz
Marinela Méndez-Pertuz
PMPaula Martínez
Paula Martínez
CBCarmen Blanco-Aparicio
Carmen Blanco-Aparicio
EGElena Gómez-Casero
Elena Gómez-Casero
AGAna Belen García
Ana Belen García
MBMaria A. Blasco
Maria A. Blasco
Telomeres and the insulin/PI3K pathway are considered hallmarks of aging and cancer. Here, we describe a role for PI3K/AKT in the regulation of TRF1, an essential component of the shelterin complex. PI3K and AKT chemical inhibitors reduce TRF1 telomeric foci and lead to increased telomeric DNA damage and fragility. We identify the PI3Kα isoform as responsible for this TRF1 inhibition. TRF1 is phosphorylated at different residues by AKT and these modifications regulate TRF1 protein stability and TRF1 binding to telomeric DNA in vitro and are important for in vivo TRF1 telomere location and cell viability. Patient-derived breast cancer PDX mouse models that effectively respond to a PI3Kα specific inhibitor, BYL719, show decreased TRF1 levels and increased DNA damage. These findings functionally connect two of the major pathways for cancer and aging, telomeres and the PI3K pathway, and pinpoint PI3K and AKT as novel targets for chemical modulation of telomere protection.

3 April 2007 in Chemistry – A European Journal
Verified
Journal Article
Closed access
PDF file
JUJayant D. Umarye
Jayant D. Umarye
TLTorben Leßmann
Torben Leßmann
AGAna B. García
Ana B. García
Victor MamaneVictor Mamane
Victor Mamane
SSStefan Sommer
Stefan Sommer
HWHerbert Waldmann
Herbert Waldmann

6 June 2003 in Chemistry – A European Journal
Verified
Journal Article
Closed access
PDF file
AVAlma Viso
Alma Viso
RPRoberto Fernández de la Pradilla
Roberto Fernández de la Pradilla
AGAna García
Ana García
CGCarlos Guerrero‐Strachan
Carlos Guerrero‐Strachan
MAMarta Alonso
Marta Alonso
ARAna Rodríguez
Ana Rodríguez

31 July 2006 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
AGAna B. Garcia
Ana B. Garcia
TLTorben Leßmann
Torben Leßmann
JUJayant D. Umarye
Jayant D. Umarye
Victor MamaneVictor Mamane
Victor Mamane
SSStefan Sommer
Stefan Sommer
HWHerbert Waldmann
Herbert Waldmann
Enantiocomplementary allylation of solid phase-bound aldehydes gives rise to a natural product-derived compound collection, including all stereoisomers of cryptocarya diacetate.